Details of the Drug

General Information of Drug (ID: DM1A5NP)

Drug Name

DI-VAL-L-DC

Synonyms

L-Valine 3',5'-diester with 4-amino-1-(2-deoxy-beta-L-erythro-pentofuranosyl)-2(1H)-pyrimidinone

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 2	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C19H31N5O6
Canonical SMILES: CC(C)C(C(=O)OCC1C(CC(O1)N2C=CC(=NC2=O)N)OC(=O)C(C(C)C)N)N
InChI: 1S/C19H31N5O6/c1-9(2)15(21)17(25)28-8-12-11(30-18(26)16(22)10(3)4)7-14(29-12)24-6-5-13(20)23-19(24)27/h5-6,9-12,14-16H,7-8,21-22H2,1-4H3,(H2,20,23,27)/t11-,12+,14+,15+,16+/m1/s1
InChIKey: BPPMYUZIZUESBY-MLEONAHRSA-N

Cross-matching ID

References

1	ClinicalTrials.gov (NCT00128544) Telbivudine Versus the Combination of Telbivudine and Valtorcitabine in Patients With Chronic Hepatitis B. U.S. National Institutes of Health.